Cargando…

The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study

Background. The etiology of the high prevalence of hypertension among patients with hemophilia (PWH) remains unknown. Methods. We compared 469 PWH in the United States with males from the National Health and Nutrition Examination Survey (NHANES) to determine whether differences in cardiovascular ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barnes, Richard F. W., Cramer, Thomas J., Sait, Afrah S., Kruse-Jarres, Rebecca, Quon, Doris V. K., von Drygalski, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124662/ https://www.ncbi.nlm.nih.gov/pubmed/27965893 http://dx.doi.org/10.1155/2016/2014201

Ejemplares similares

The role of point-of-Care Musculoskeletal Ultrasound for Routine Joint evaluation and management in the Hemophilia Clinic - A Real World Experience
por: Gallastegui, N, et al.
Publicado: (2022)

Quantitative measurements of haemophilic joint tissues by point‐of‐care musculoskeletal ultrasound: Associations with clinical and functional joint outcome parameters
por: Mesleh Shayeb, Akram, et al.
Publicado: (2021)

Consistency of serial ultrasonographic joint tissue measurements by the Joint (tissue)Activity and Damage Exam (JADE) protocol in relation to hemophilic joint health parameters
por: Barnes, Richard F. W., et al.
Publicado: (2023)

Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics
por: Zhou, Jenny Y., et al.
Publicado: (2019)

Acquired hemophilia A: emerging treatment options
por: Janbain, Maissaa, et al.
Publicado: (2015)

Knee Fat Pad Volumes in Patients with Hemophilia and Their Relationship with Osteoarthritis
por: von Drygalski, Annette, et al.
Publicado: (2017)

Balance, falls, and exercise: Beliefs and experiences in people with hemophilia: A qualitative study
por: Flaherty, Lorraine M., et al.
Publicado: (2017)

Evaluating Gene Therapy as a Potential Paradigm Shift in Treating Severe Hemophilia
por: Thornburg, Courtney D., et al.
Publicado: (2023)

Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting
por: Bakeer, Nihal, et al.
Publicado: (2021)

Application of a hemophilia mortality framework to the Emicizumab Global Safety Database
por: Peyvandi, Flora, et al.
Publicado: (2020)

Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
por: Nguyen, S., et al.
Publicado: (2019)

Cardiovascular Risk Factors in Patients with Congenital Hemophilia: A Focus on Hypertension
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Establishment of a framework for assessing mortality in persons with congenital hemophilia A and its application to an adverse event reporting database
por: Pipe, Steven W., et al.
Publicado: (2020)

Untreated bleeds in people with hemophilia A in a noninterventional study and intrapatient comparison after initiating emicizumab in HAVEN 1–3
por: Callaghan, Michael U., et al.
Publicado: (2022)

Stable and durable factor IX levels in patients with hemophilia B over 3 years after etranacogene dezaparvovec gene therapy
por: von Drygalski, Annette, et al.
Publicado: (2022)

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies
por: Kruse-Jarres, Rebecca, et al.
Publicado: (2022)

Socioeconomic participation of persons with hemophilia: Results from the sixth hemophilia in the Netherlands study
por: van Balen, Erna C., et al.
Publicado: (2022)

Prepartum Anemia and Risk of Postpartum Hemorrhage: A Meta-Analysis and Brief Review
por: Glonnegger, Hannah, et al.
Publicado: (2023)

Comorbidities of cardiovascular disease and cancer in hemophilia patients
por: Wang, Jiaan-Der
Publicado: (2016)

Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective study
por: Van Der Valk, Paul, et al.
Publicado: (2022)

An Engineered Factor Va Prevents Bleeding Induced by Anticoagulant wt Activated Protein C
por: von Drygalski, Annette, et al.
Publicado: (2014)

How we manage cardiovascular disease in patients with hemophilia
por: Franchini, Massimo, et al.
Publicado: (2023)

Anticoagulation for Stroke Prevention after Restoration of Haemostasis with Emicizumab in Acquired Haemophilia A
por: Al-Banaa, Kadhim, et al.
Publicado: (2021)

Optimization of prophylaxis for hemophilia A
por: Herbert, Robert D., et al.
Publicado: (2018)

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
por: Portuguese, Andrew Jay, et al.
Publicado: (2021)

Vascular Health Triad in Humans With Hypertension—Not the Usual Suspects
por: Ranadive, Sushant M., et al.
Publicado: (2021)

Long-Term Antithrombotic Treatments Prescribed for Cardiovascular Diseases in Patients with Hemophilia: Results from the French Registry
por: Guillet, Benoît, et al.
Publicado: (2021)

Maternal death and postpartum hemorrhage in sub‐Saharan Africa – A pilot study in metropolitan Mozambique
por: Lancaster, Lian, et al.
Publicado: (2020)

A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE)
por: Konkle, Barbara A, et al.
Publicado: (2021)

Correction: Optimization of prophylaxis for hemophilia A
por: Herbert, Robert D., et al.
Publicado: (2018)

Principles of care for acquired hemophilia
por: Dolan, Gerry, et al.
Publicado: (2021)

Pulmonary Embolism Does Not Have an Unusually High Incidence Among Hospitalized COVID19 Patients
por: Gallastegui, Nicolas, et al.
Publicado: (2021)

Serum 25-Hydroxyvitamin D and Diet Mediates Vaso-Occlusive Related Hospitalizations in Sickle-Cell Disease Patients
por: McCaskill, Michael L., et al.
Publicado: (2018)

Consensus Review of the Treatment of Cardiovascular Disease in People With Hemophilia A and B
por: Ferraris, Victor A., et al.
Publicado: (2015)

Practice of Iranian Adolescents with Hemophilia in Prevention of Complications of Hemophilia
por: Valizadeh, Leila, et al.
Publicado: (2015)

Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review
por: Galllastegui Crestani, Nicolas, et al.
Publicado: (2020)

Macroscopic hematuria as a risk factor for hypertension in ageing people with hemophilia and a family history of hypertension
por: Qvigstad, Christian, et al.
Publicado: (2020)

The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program
por: Owaidah, Tarek, et al.
Publicado: (2017)

Hemophilia gene therapy knowledge and perceptions: Results of an international survey
por: Peyvandi, Flora, et al.
Publicado: (2020)

Hemophilia of orbit
por: Karunanithi, Gunaseelan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_l5lan8pi6m359h7vlun2ddeubh